AN2 Therapeutics Inc banner

AN2 Therapeutics Inc
NASDAQ:ANTX

Watchlist Manager
AN2 Therapeutics Inc Logo
AN2 Therapeutics Inc
NASDAQ:ANTX
Watchlist
Price: 1.06 USD 0.95% Market Closed
Market Cap: $29m

Income Statement

Earnings Waterfall
AN2 Therapeutics Inc

Income Statement
AN2 Therapeutics Inc

Rotate your device to view
Income Statement
Currency: USD
Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(42)
(51)
(57)
(63)
(70)
(72)
(71)
(65)
(55)
(50)
(41)
(37)
Selling, General & Administrative
(13)
(15)
(14)
(15)
(15)
(14)
(15)
(15)
(14)
(14)
(15)
(14)
Research & Development
(30)
(36)
(43)
(49)
(55)
(58)
(56)
(50)
(40)
(34)
(25)
(23)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
(2)
(2)
0
Operating Income
(42)
N/A
(51)
-20%
(57)
-12%
(63)
-11%
(70)
-10%
(72)
-3%
(71)
+1%
(65)
+9%
(55)
+16%
(50)
+8%
(41)
+17%
(37)
+10%
Pre-Tax Income
Interest Income Expense
1
2
3
4
0
4
5
4
5
5
4
3
Non-Reccuring Items
0
0
0
0
0
0
0
(2)
(2)
0
0
0
Total Other Income
(0)
0
0
0
5
0
0
0
0
0
0
0
Pre-Tax Income
(41)
N/A
(49)
-19%
(54)
-12%
(60)
-10%
(65)
-8%
(66)
-2%
(65)
+2%
(61)
+6%
(51)
+16%
(46)
+11%
(38)
+17%
(34)
+10%
Net Income
Income from Continuing Operations
(41)
(49)
(54)
(60)
(65)
(66)
(65)
(61)
(51)
(46)
(38)
(34)
Net Income (Common)
(43)
N/A
(49)
-14%
(54)
-12%
(60)
-10%
(65)
-8%
(66)
-2%
(65)
+2%
(61)
+6%
(51)
+16%
(46)
+11%
(38)
+17%
(34)
+10%
EPS (Diluted)
-2.79
N/A
-2.52
+10%
-2.8
-11%
-2.32
+17%
-2.74
-18%
-2.21
+19%
-2.16
+2%
-2.04
+6%
-1.72
+16%
-1.52
+12%
-1.25
+18%
-1.13
+10%